Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (45) Prempro & Premphase (conjugated estrogens/medroxyprogesterone acetate tablets), Wyeth,
...Newly Approved Drug Therapies (45) Prempro & Premphase (conjugated estrogens/medroxyprogesterone acetate tablets), Wyeth, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Prempro & Premphase (conjugated estrogens/medroxyprogesterone acetate tablets) Company: Wyeth Approval Status: Approved November 1995 Treatment Area: postmenopausal hormone replacement ...
View Page

2.  Newly Approved Drug Therapies (530) Cenestin, Duramed Pharmaceuticals,
...Obstetrics/Gynecology General Information Cenestin has been approved to reduce moderate or severe menopausal symptoms. Estrogens are hormones made by the ovaries of normal women. Between ages 45 and 55, the ovaries normally stop making estrogens. This leads to a drop in body estrogen levels which causes menopause (the end of ...
View Page

3.  Newly Approved Drug Therapies (1071) Premarin (conjugated estrogens), Wyeth,
...Newly Approved Drug Therapies (1071) Premarin (conjugated estrogens), Wyeth, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Premarin (conjugated estrogens) Company: Wyeth Approval Status: Approved July of 2003 Treatment Area: prevention of postmenopausal osteoporosis and ...
View Page

4.  Study Posting (709) Trial #64274, Post Menopause, Palo Alto, CA
...Posting (709) Trial #64274, Post Menopause, Palo Alto, CA Trial Information Are you currently on Estrogen Replacement Therapy and Unsure of what to do? Are you a woman between the ages of 50-65? Are you currently on estrogen replacement therapy and are unsure of what to do? Should you stay on or go ...
View Page

5.  Newly Approved Drug Therapies (775) Faslodex (fulvestrant), AstraZeneca,
...It is indicated for use in postmenopausal women whose disease has progressed after receiving anti-estrogen therapy (such as tamoxifen). The therapy is given as a once-a-month intramuscular injection ...
...receptor tests can be conducted to determine whether a patient's cancer is responsive to estrogen (known as estrogen receptor positive). If the cancer is found to be estrogen receptor positive ...
View Page

6.  Study Posting (4912) Trial #137325, Breast Cancer, Paramus, NJ
...in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Estrogen can cause the growth of breast cancer cells. Hormone therapy may fight breast cancer by blocking the use of estrogen by the tumor cells or by lowering the amount of estrogen the body makes. Drugs ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (171), Hormone Replacement Therapy: Menopause
...July 15, 2002 The National Institutes of Health has halted a large multicenter trial evaluating estrogen plus progestin due to an increased risk of invasive breast cancer. The randomized, placebo-controlled estrogen/progestin component of the Women's Health Initiative (WHI) included 16,608 women ages 50 ...
View Page

8.  Study Posting (1918) Trial #160124, Breast Cancer, Savannah, GA
...Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) ECOG PACCT-1 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy may fight breast cancer by blocking the use of estrogen by the tumor cells or by lowering the amount of estrogen the body makes. Drugs ...
View Page

9.  Newly Approved Drug Therapies (576) Estradiol Transdermal System, Wyeth,
...Approved September 1999 Treatment Area: Treatment of vulvar vaginal atrophy and vasomotor symptoms General Information Estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal intracellular human estrogen ...
View Page

10.  Newly Approved Drug Therapies (532) Climara, Berlex Laboratories,
...Status: Approved June 1999 Treatment Area: Obstetrics/Gynecology General Information The Climara® system provides systemic estrogen replacement therapy by releasing 17b-estradiol, the major estrogenic hormone secreted by the human ovary ...
...at the end of week three in 11% of Estraderm® and 9% of Climara® subjects. Estrogens should not be used in individuals with any of the following conditions: • Known or suspected ...
View Page

11.  Study Posting (180) Trial #12682, Dementia, New York, NY
...York, NY Trial Information Dementia Prevention Study for Healthy Women Several studies have shown that estrogen use may reduce the risk of dementia and memory loss. Researchers at Columbia University's Gertrude H. Sergievsky Center are conducting a study to determine if estrogen can prevent memory loss and Alzheimer's disease. Healthy women over the age of 65 ...
View Page

12.  Study Posting (1918) Trial #161384, Breast Cancer, Savannah, GA
...Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer NSABP B-42 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. It is not yet known whether letrozole is more effective than a ...
View Page

13.  Newly Approved Drug Therapies (248) Estrostep (norethindrone acetate and ethinyl estradiol), Warner-Lambert,
...marketed in more than 10 years. Estrostep works by providing low, gradually increasing amounts of estrogen (20, 30, 35 mcg ethinyl estradiol) with a low, constant dose of progestin (one mg norethindrone acetate). Monophasic birth control pills contain a constant doe of estrogen and progestin. Triphasics change the dose of progestin throughout the cycle while keeping the estrogen ...
View Page

14.  Study Posting (180) Trial #13266, Alzheimer's Disease, New York, NY
...York, NY Trial Information Dementia Prevention Study for Healthy Women Several studies have shown that estrogen use may reduce the risk of dementia and memory loss. Researchers at Columbia University's Gertrude H. Sergievsky Center are conducting a study to determine if estrogen can prevent memory loss and Alzheimer's disease. Healthy women over the age of 65 ...
View Page

15.  Newly Approved Drug Therapies (173) Estrostep (norethindrone acetate and ethinyl estradiol), Parke-Davis,
...approved as an oral contraceptive. Other birth control pills usually contain a constant dose of estrogen and progestin, or change the dose of progestin throughout the cycle. Estrostep is the only oral contraceptive to combine low, gradually increasing amounts of estrogen (20, 30, 35 mcg ethinyl estradiol) with a low, constant dose of progestin (one mg ...
View Page

16.  Study Posting (1465) Trial #21759, Memory Loss, Ridgewood, NJ
...Ridgewood, NJ Trial Information Dementia Prevention Study for Healthy Women Several studies have shown that estrogen use may reduce the risk of dementia and memory loss. Researchers at Columbia University's ...
...Center, in collaboration with experts around the country, are conducting a study to determine if estrogen can prevent memory loss and Alzheimer's disease. Healthy women over the age of 65 ...
View Page

17.  Study Posting (4287) Trial #155660, Menopause, Plantation, FL
...Randomized, Placebo- and Active-Controlled Efficacy and Safety Study of the Effects of Bazedoxifene/Conjugated Estrogens Combinations on Endometrial Hyperplasia and Prevention of Osteoporosis in Postmenopausal Women This is a research ...
...comply to study protocol and complete all study visits Patient Exclusion Criteria: • Use of oral estrogen-, progestin-, androgen-, or SERM-containing drug products within the last 8 weeks; use of transdermal ...
View Page

18.  Study Posting (180) Trial #21635, Memory Loss, New York, NY
...York, NY Trial Information Dementia Prevention Study for Healthy Women Several studies have shown that estrogen use may reduce the risk of dementia and memory loss. Researchers at Columbia University's ...
...Center, in collaboration with experts around the country, are conducting a study to determine if estrogen can prevent memory loss and Alzheimer's disease. Healthy women over the age of 65 ...
View Page

19.  Study Posting (1465) Trial #21758, Alzheimer's Disease, Ridgewood, NJ
...Ridgewood, NJ Trial Information Dementia Prevention Study for Healthy Women Several studies have shown that estrogen use may reduce the risk of dementia and memory loss. Researchers at Columbia University's ...
...Center, in collaboration with experts around the country, are conducting a study to determine if estrogen can prevent memory loss and Alzheimer's disease. Healthy women over the age of 65 ...
View Page

20.  Newly Approved Drug Therapies (590) Femhrt Tablets, Parke-Davis,
...and the prevention of osteoporosis General Information femhrt 1/5 is a combination of an estrogen hormone, ethinyl estradiol , and a progestin hormone, norethindrone acetate . It should be used to relieve ...
...For the treatment of menopausal symptoms: Femhrt 1/5 will replace the dropping levels of estrogen in women experiencing menopause. The treatment will reduce moderate to severe symptoms, such as hot ...
View Page